Figure 11. Relative changes (%) in the degree of temporal coupling between different motor units (evaluated as in Fig. 6) for wind evoked fictive flight following treatment with (from left to right): octopamine (OA, 5 mM), the octopamine receptor antagonist epinastine (EP, 1 mM), tyramine (TA, 5 mM) and the tyramine receptor antagonist yohimbine (YO, 1 mM).

Data from same preparations as for Fig. 9. A WD-WE latency, B phase of wing elevator in wing depressor cycle (WE/WD-WD), C WD-TD latency (coupling of leg unit TD to the wing unit WD), D phase of leg unit in wing depressor cycle (TD/WD-WD). Columns give the median, ticks the IQR and asterisks significant differences (Wilcoxon Signed Rank test *p<0.05, **p<0.01).